Markey touts insulin price cap for Medicare recipients at local health center - Boston Herald
U.S. Sen. Ed Markey is making the rounds to highlight a $35-a-month insulin price cap for Medicare recipients. “We all too often see the downstream consequences of barriers to care, including the high cost of prescription drugs like insulin and other medications used to treat diabetes,” said Christian Arbelaez, Chief of Emergency Services at Boston Medical Center. “I care for these patients in the emergency department when they present with life-threatening emergencies, like heart attacks, strokes and sepsis — precipitated by the lack of insulin.” Markey visited the center this week to speak about the policy included in the Inflation Reduction Act passed in 2022. Under the law, the price of insulin will be capped at $35 a month for seniors on Medicare. Insulin may cost over $1,000 a month for those with poor or no health insurance, Markey said. One in five Americans over the age of 65 — eligible for Medicare — has been diagnosed with type 1 or type 2 diabetes, according to a 2017 C...